Replies to post #123831 on Biotech Values

[JJM760]

So in short (pun intended) I think he thought it a good short for many reasons. I don't know his initial price but the time of the first article was in the ~4.50 - ~5 range so if one shorted then they would have done pretty well.

I think he shorted around $5. Nice trade, good for him. I'm not as big a fan of Marty as you. His bash fest certainly didn't hurt his cause. SC being approved going against blue dye alone basically throws his horseh%#t opinion out the window. So far he is at least 1/3 completely wrong and he made a killing. Sounds like Wall Street at it's finest.

Lymphoseek NDA will be filed fairly soon and I think it has a good shot at being approved IMO. Now how much of the market it takes from blue dye and SC remains to be seen. Neop longs claim it is a better product than the SOC. Cardinal Health might have a tough sales job on their hands.

[DewDiligence]

NEOP submits Lymphoseek NDA:

http://finance.yahoo.com/news/Neoprobe-Submits-New-Drug-bw-1622351970.html?x=0&.v=1